Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.

[1]  Takeshi Kimura,et al.  β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure. , 2013, International journal of cardiology.

[2]  A. Íñiguez,et al.  Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.

[3]  Jane A. Linderbaum,et al.  2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  Harlan M Krumholz,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[5]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[6]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[7]  Deepak L. Bhatt,et al.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. , 2012, JAMA.

[8]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[9]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[10]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[11]  N. Sato,et al.  Secondary preventive effects of a calcium antagonist for ischemic heart attack: randomized parallel comparison with β-blockers. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[12]  K. Swedberg,et al.  Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction. , 2009, Acta medica Scandinavica.

[13]  M. Walsh,et al.  Practolol in acute myocardial infarction. , 2009, Acta medica Scandinavica. Supplementum.

[14]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[15]  D. Altman,et al.  Chapter 8: Assessing risk of bias in included studies , 2008 .

[16]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[17]  H. Katus,et al.  Acute Reduction of Myocardial Infarct Size By a Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Is Mediated by Endothelial Nitric Oxide Synthase , 2003, Journal of cardiovascular pharmacology.

[18]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[19]  O. Ben‐Yehuda,et al.  Esmolol in acute ischemic syndromes. , 2002, American heart journal.

[20]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[21]  J. Galcerá-Tomás,et al.  Effects of Early Use of Atenolol or Captopril on Infarct Size and Ventricular Volume: A Double-Blind Comparison in Patients With Anterior Acute Myocardial Infarction , 2001, Circulation.

[22]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[23]  M. Brodsky,et al.  Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. , 1999, Journal of the American College of Cardiology.

[24]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[25]  J. Herlitz,et al.  Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarction. , 1999, American heart journal.

[26]  A. Salustri,et al.  Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. , 1999, Giornale italiano di cardiologia.

[27]  T. Hedner,et al.  A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction – the MEMO study , 1999, Journal of internal medicine.

[28]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[29]  R. Senior,et al.  Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. , 1997, Circulation.

[30]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.

[31]  J. Boissel,et al.  Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus. , 1997, The American journal of cardiology.

[32]  J. Alpert,et al.  Does aspirin consumption affect the presentation or severity of acute myocardial infarction? , 1995, Archives of internal medicine.

[33]  F. Van de Werf,et al.  Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. , 1993, Journal of the American College of Cardiology.

[34]  P. Schwartz,et al.  Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions , 1992 .

[35]  D. Warrell.  CEREBRAL CONSUMPTION OF GLUCOSE - REPLY , 1989 .

[36]  G. Olsson.  Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial. , 1988, American heart journal.

[37]  J. Lázzari,et al.  Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction. , 1987, Circulation.

[38]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[39]  M. O'Rourke,et al.  Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction. , 1985, Australian and New Zealand journal of medicine.

[40]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[41]  G. Cran,et al.  Very early intervention with metoprolol in suspected acute myocardial infarction. , 1985, European heart journal.

[42]  R. Norris,et al.  PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOL , 1984, The Lancet.

[43]  A. Jaffe,et al.  Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. , 1984, The New England journal of medicine.

[44]  Pedersen Tr.  The Norwegian Multicenter Study of Timolol after Myocardial Infarction. , 1983 .

[45]  R. Peto,et al.  Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. , 1983, Circulation.

[46]  S. Yusuf,et al.  Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. , 1983, British medical journal.

[47]  G. Sutton,et al.  A long-term prevention study with oxprenolol in coronary heart disease. , 1982, The New England journal of medicine.

[48]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[49]  S. Ralston,et al.  DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATION , 1982, The Lancet.

[50]  P. Hoff,et al.  One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. , 1982, British medical journal.

[51]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[52]  S. Taylor,et al.  An early intervention secondary prevention study with oxprenolol following myocardial infarction. , 1981, European heart journal.

[53]  J. Hampton,et al.  RANDOMISED PLACEBO-CONTROLLED TRIAL COMPARING OXPRENOLOL WITH DISOPYRAMIDE PHOSPHATE IN IMMEDIATE TREATMENT OF SUSPECTED MYOCARDIAL INFARCTION , 1980, The Lancet.

[54]  J. Lewis,et al.  Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. , 1980, British heart journal.

[55]  J. Hampton,et al.  Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. , 1980, British medical journal.

[56]  F. Pedersen,et al.  EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Results , 1979, The Lancet.

[57]  T. Wenkart.  PROPRANOLOL IN ACUTE MYOCARDIAL INFARCTION , 1979, The Medical journal of Australia.

[58]  P. Thompson,et al.  Enzymatic Indices of Myocardial Necrosis: Influence on Short- and Long-Term Prognosis After Myocardial Infarction , 1979, Circulation.

[59]  H. Keen,et al.  ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.

[60]  S. P. Allison,et al.  ELEMENTAL DIETS , 1975, The Lancet.

[61]  G. Ahlmark,et al.  REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION , 1974 .

[62]  G. Ahlmark,et al.  Letter: Reduction of sudden Deaths after myocardial infarction. , 1974, Lancet.

[63]  L. Wilhelmsen,et al.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. , 1974, Lancet.

[64]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[65]  Norris Rm,et al.  Alprenolol in acute myocardial infarction: Double-blind trial. , 1970 .

[66]  Fuccella Lm.  Trasicor: review of the pharmacology and clinical results. , 1969 .

[67]  R. Norris,et al.  Trial of propranolol in acute myocardial infarction. , 1968, British medical journal.

[68]  E. Sowton.  Beta-adrenergic blockade in cardiac infarction. , 1968, Progress in cardiovascular diseases.

[69]  R. Balcon,et al.  A controlled trial of propranolol in acute myocardial infarction. , 1967, American heart journal.

[70]  W. Belton.  Consultants' views of general practitioners , 1967 .

[71]  B. Nielsen,et al.  Absence of prophylactic effect of propranolol in myocardial infarction. , 1966, Lancet.

[72]  P. Snow.  Treatment of acute myocardial infarction with propranolol. , 1966, The American journal of cardiology.

[73]  B. Mittra.  Potassium, glucose, and insulin in treatment of myocardial infarction. , 1965, Lancet.

[74]  Calvert Ca.  Development of neurosurgery. , 1946 .

[75]  V. Fuster,et al.  Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial , 2013 .

[76]  S. Laurent,et al.  Coronary artery disease: Are β-blockers truly helpful in patients with CAD? , 2013, Nature Reviews Cardiology.

[77]  E. V. Simon.  Beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease , 2013 .

[78]  K. Thorlund,et al.  Bmc Medical Research Methodology Open Access Estimating Required Information Size by Quantifying Diversity in Random-effects Model Meta-analyses , 2022 .

[79]  K. Thorlund,et al.  Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. , 2008, Journal of clinical epidemiology.

[80]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi , 2004, The Canadian journal of cardiology.

[81]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[82]  K. Swedberg,et al.  Effects on mortality during five years follow-up after early intervention with metoprolol in suspected acute myocardial infarction , 1988 .

[83]  D. Chamberlain,et al.  Effect of labetalol on indices of myocardial necrosis in patients with suspected acute infarction. , 1987, European heart journal.

[84]  J. Willerson,et al.  The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. , 1987, European heart journal.

[85]  Johan Herlitz,et al.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.

[86]  T. Smirnova,et al.  Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles. , 1984, Cor et vasa.

[87]  A. Carter.  Letter: Pyridoxine contraindicated in parkinsonism. , 1973, Lancet.

[88]  R. Briant,et al.  Alprenolol in acute myocardial infarction: Double-blind trial. , 1970, The New Zealand medical journal.

[89]  J. Merrett,et al.  Clinical Trial of Propranolol in Acute Myocardial Infarction , 1967, The Ulster medical journal.